Jagsonpal Pharmaceuticals Limited (BOM: 507789)
India
· Delayed Price · Currency is INR
655.25
0.00 (0.00%)
At close: Jan 3, 2025
Jagsonpal Pharmaceuticals Revenue
Jagsonpal Pharmaceuticals had revenue of 746.92M INR in the quarter ending September 30, 2024, with 29.16% growth. This brings the company's revenue in the last twelve months to 2.27B, down -2.88% year-over-year. In the fiscal year ending March 31, 2024, Jagsonpal Pharmaceuticals had annual revenue of 2.09B, down -11.83%.
Revenue (ttm)
2.27B
Revenue Growth
-2.88%
P/S Ratio
n/a
Revenue / Employee
2.21M
Employees
1,025
Market Cap
17.40B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 2.09B | -280.12M | -11.83% |
Mar 31, 2023 | 2.37B | 191.30M | 8.79% |
Mar 31, 2022 | 2.18B | 296.38M | 15.77% |
Mar 31, 2021 | 1.88B | 293.78M | 18.53% |
Mar 31, 2020 | 1.59B | -82.58M | -4.95% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Apr 1, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,249.38B |
Tata Consultancy Services | 2,486.92B |
HDFC Bank | 2,761.06B |
Bharti Airtel | 1,554.78B |
ICICI Bank | 1,638.51B |
Infosys | 1,578.13B |
State Bank of India | 3,360.28B |
ITC Limited | 751.35B |